Skip to content

Effect of Repetitive transcranial magnetic stimulation for the Treatment of Chronic Insomnia and the underlying brain mechanism

Effect of Transcranial Alternating Current Stimulation for the Treatment of Chronic Insomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077939
Enrollment
Unknown
Registered
2023-11-24
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

Healthy control:none
Experimental group 1:rTMS by figure-of-eight coil
Experimental group 2:rTMS by double-cone coil

Sponsors

Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Chronic insomnia patient inclusion criteria: 1) meats the clinical diagnostic criteria for primary chronic insomnia in DSM-5 criteria); 2) PSQI=5, ISI=8; 3) complain of impaired daytime functioning (=2 on component 5 and/or =2 on component 7 of the Chinese version of the Pittsburgh Sleep Quality Index [PSQI]); 4) aged 18-65 years, gender unlimited; 5) without anxiety (HAMA <= 14, excluding item 4) or depression (HAMD-24 < 20, excluding items 4-6); 6) is willing to discontinue their sleep medication for a period of 2 weeks (washout period) prior to enrolling in the study or not taking any treatment for insomnia for at least 2 weeks before the baseline visit. Healthy control inclusion criteria: 1) a total score <5 on the PSQI and a total score = 8 on the ISI; 2) aged 18–65 years; 3) without frequent jet lag or not doing night shift work; 4) right-handed; 5) no symptoms or history of psychiatric disorders

Exclusion criteria

Exclusion criteria: Chronic insomnia patient exclusion criteria: 1) presence of other sleep disorders including sleep apnea, periodic limb movements, parasomnias, hypersomnia, or participation in concurrent clinical trials; 2) with frequent jet lag or doing night shift work; 3) previous diagnosis of neurological and mental diseases (such as Parkinson's disease and depression); 4) Epworth Sleepiness Scale (ESS) >11; 5) being pregnant or lactating, or plans to become pregnant during the study period; 6); current smoking of more than 10 cigarettes per day, consumption of alcohol (no more than 2 standard alcoholic drinks per day for a period> 1 month in the preceding year), caffeinated beverage/pill consumption was estimated to contain more than 300 mg of caffeine daily (approximately 3 standard cups of coffee); 7) Contraindications for MRI /rTMS (e.g. having a cochlear implant, a cardiac pacemaker, an implanted device (i.e., deep brain stimulation), or metal in the brain). Healthy control exclusion criteria: Contraindications for MRI /rTMS; psychiatric disorders (HAMD-24=8, HAMA=6); pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index(PSQI);Insomnia Severity Index (ISI);Self-rating depression scale (SDS);Stroop test;

Secondary

MeasureTime frame
Hamilton Anxiety Scale (HAMA);Hamilton Depression Scale (HAMD);Self-Rating Anxiety Scale(SAS);Montreal Cognitive Assessment (MoCA) Beijing version;Color Trails Test (CTT);Digital Span Test (DST);Symbol Digit Modalities Testt (DSST);

Countries

China

Contacts

Public ContactXiquan Hu

The Third Affiliated Hospital of Sun Yat-sen University

huxiquan@mail.sysu.edu.cn+86 189 2210 2910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026